Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities

NACompletedINTERVENTIONAL
Enrollment

2,164

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

June 3, 2023

Study Completion Date

June 3, 2023

Conditions
SARS-CoV-2
Interventions
BEHAVIORAL

Family Risk Messaging

"Family risk framing may engender concern for loved ones. It may also make it easier to mentally simulate family burdens with COVID-19 such as knowing how several people in the family becoming sick could adversely affect the lives of everyone in the family. Households randomized to family risk messaging will receive the following message: Antibody testing will help you understand your family's risk of getting COVID-19."

BEHAVIORAL

Personal Risk Messaging

"Personal risk framing may engender concern for oneself. Households randomized to personal risk messaging will receive the following message: Antibody testing will help you understand your risk of getting COVID-19."

BEHAVIORAL

Loss Protection

Household members are offered a baseline incentive with a 90% (9 in 10) chance of $60 and receive insurance on winning the baseline incentive for repeat antibody testing.

BEHAVIORAL

Lottery Incentive

Household members are offered a baseline incentive with a 90% (9 in 10) chance of $60 and receive a bonus lottery incentive with a 4 small (1 in 25) chance of winning $150 for repeat antibody testing.

Trial Locations (1)

90022

AltaMed Health, Los Angeles

All Listed Sponsors
collaborator

AltaMed Health Services Corporation

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Southern California

OTHER